The rising interest in GLP-1 agonists for diabetes has led to a question about formats: patches versus capsules. Traditionally , GLP-1 therapies were exclusively available in oral form, but the emergence https://louisetekr919040.mpeblog.com/73926860/glp-1-transdermal-delivery-systems-vs-oral-medications-is-suitable-for-the-patient